M. Lebmeier
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Pharmaceutical Economics and Policy 2
-
- Respiratory viral infections research 4
- Co-authors
- Mark Nuijten (4 shared papers)Dyfrig Hughes (1 shared paper)Maribel Salas (1 shared paper)L. Pericleous (3 shared papers)Dawn Lee (4 shared papers)Anthony J. Hatswell (2 shared papers)C Poole (1 shared paper)Rachid Rafia (1 shared paper)
- Journals
- Value in Health (11 papers)Journal of Medical Economics (2 papers)Mycoses (1 paper)PharmacoEconomics (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
M. Lebmeier
19 papers receiving 397 citations
Peers
Comparison fields: 5 of 58
- Family Practice 62
- Rheumatology 72
- Epidemiology 147
- Pulmonary and Respiratory Medicine 66
- Geriatrics and Gerontology 6
Countries citing papers authored by M. Lebmeier
This map shows the geographic impact of M. Lebmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lebmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lebmeier more than expected).
Fields of papers citing papers by M. Lebmeier
This network shows the impact of papers produced by M. Lebmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lebmeier. The network helps show where M. Lebmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lebmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 99 | |
| 2 | 2007 | 73 | |
| 3 | 2014 | 40 | |
| 4 | 2011 | 38 | |
| 5 | 2010 | 37 | |
| 6 | 2008 | 32 | |
| 7 | 2009 | 21 | |
| 8 | 2012 | 19 | |
| 9 | 2015 | 17 | |
| 10 | 2009 | 17 | |
| 11 | 2020 | 9 | |
| 12 | 2023 | 5 | |
| 13 | 2012 | 3 | |
| 14 | 2012 | 3 | |
| 15 | 2011 | 2 | |
| 16 | 2011 | 2 | |
| 17 | 2005 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2005 | 1 | |
| 20 | 2026 | 0 |
About M. Lebmeier
M. Lebmeier is a scholar working on Economics and Econometrics, Epidemiology, Infectious Diseases, Rheumatology and Genetics, having authored 22 papers that have together received 420 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Respiratory viral infections research (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Antifungal resistance and susceptibility (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Family Practice (62 citations), Rheumatology (72 citations), Epidemiology (147 citations), Pulmonary and Respiratory Medicine (66 citations) and Geriatrics and Gerontology (6 citations). M. Lebmeier has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Mark Nuijten, Dyfrig Hughes, Maribel Salas, L. Pericleous, Dawn Lee, Anthony J. Hatswell, C Poole, Rachid Rafia, Robin Christensen and Roberta Ara. Their work appears in journals such as Value in Health, Journal of Medical Economics, Mycoses, PharmacoEconomics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.